SAREPTA THERAPEUTICS INC (SRPT) Forecast, Price Target & Analyst Ratings

NASDAQ:SRPT • US8036071004

Current stock price

23.23 USD
+1.1 (+4.97%)
At close:
23.15 USD
-0.08 (-0.34%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SAREPTA THERAPEUTICS INC (SRPT).

Forecast Snapshot

Consensus Price Target

Price Target
$30.27
+ 30.32% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$1.07
Revenue Estimate
485.1M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
67.27%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$30.27
Upside
+ 30.32%
From current price of $23.23 to mean target of $30.27, Based on 33 analyst forecasts
Low
$5.05
Median
$20.40
High
$194.25

Price Target Revisions

1 Month
-2.11%
3 Months
0.41%

Price Target Summary

33 Wall Street analysts provided a forecast for the next 12 months for SRPT. The average price target is 30.27 USD. This implies a price increase of 30.32% is expected in the next year compared to the current price of 23.23.
The average price target has been revised upward by 0.41% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SRPT Current Analyst RatingSRPT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15

Analyst Ratings History

SRPT Historical Analyst RatingsSRPT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 10 20 30

Analyst Ratings Consensus

ChartMill Buy Consensus
67.27%
SRPT was analyzed by 33 analysts. The buy percentage consensus is at 67. So analysts seem to be have mildly positive about SRPT.
In the previous month the buy percentage consensus was at a similar level.
SRPT was analyzed by 33 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-26NeedhamReiterate Underperform -> Underperform
2026-03-26CitigroupMaintains Sell -> Sell
2026-03-19OppenheimerReiterate Outperform -> Outperform
2026-03-13MizuhoMaintains Outperform -> Outperform
2026-03-10CitigroupMaintains Sell -> Sell
2026-03-02HC Wainwright & Co.Reiterate Sell -> Sell
2026-02-27Wells FargoMaintains Overweight -> Overweight
2026-01-27HC Wainwright & Co.Reiterate Sell -> Sell
2026-01-23WedbushMaintains Outperform -> Outperform
2026-01-14HC Wainwright & Co.Reiterate Sell -> Sell
2025-12-09WedbushInitiate Outperform
2025-11-05MizuhoUpgrade Neutral -> Outperform
2025-11-05GuggenheimMaintains Buy -> Buy
2025-11-05BarclaysMaintains Equal-Weight -> Equal-Weight
2025-11-05Wells FargoMaintains Overweight -> Overweight
2025-11-04BairdMaintains Neutral -> Neutral
2025-10-30Piper SandlerMaintains Neutral -> Neutral
2025-09-22BMO CapitalUpgrade Market Perform -> Outperform
2025-09-15GuggenheimReiterate Buy -> Buy
2025-09-09Leerink PartnersMaintains Market Perform -> Market Perform
2025-08-25HC Wainwright & Co.Reiterate Sell -> Sell
2025-08-21B of A SecuritiesMaintains Underperform -> Underperform
2025-08-20B of A SecuritiesMaintains Underperform -> Underperform
2025-08-15Deutsche BankMaintains Sell -> Sell
2025-08-07Wells FargoMaintains Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$1.07
Revenue Estimate
485.1M
Revenue Q2Q
-34.87%
EPS Q2Q
123.23%
Number of Analysts
23

Next Earnings Revisions

Revenue (1 Month)
25.90%
Revenue (3 Months)
26.31%
EPS (1 Month)
205.67%
EPS (3 Months)
260.40%

Next Earnings Summary

SRPT is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is 1.07 USD and the consensus revenue estimate is 485.10M USD.
The next earnings revenue estimate has been revised upward by 26.31% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
SRPT revenue by date.SRPT revenue by date.
1.243B
33.26%		1.902B
52.97%		2.198B
15.58%		1.764B
-19.75%		1.438B
-18.48%		1.462B
1.67%		1.538B
5.20%		1.496B
-2.73%		1.438B
-3.88%		1.461B
1.60%		1.538B
5.27%
EBITDA
YoY % growth
SRPT ebitda by date.SRPT ebitda by date.
-223.427M
54.80%		255.805M
214.49%		-447.951M
-275.11%		402.48M
189.85%		121.39M
-69.84%		110.98M
-8.58%		153.91M
38.68%		104.65M
-32.01%		N/AN/AN/A
EBIT
YoY % growth
SRPT ebit by date.SRPT ebit by date.
-267.824M
50.05%		218.081M
181.43%		-492.472M
-325.82%		326.49M
166.30%		195.59M
-40.09%		110.68M
-43.41%		160.8M
45.28%		111.4M
-30.72%		13.822M
-87.59%		-5.896M
-142.66%		-26.096M
-342.59%
Operating Margin
SRPT operating margin by date.SRPT operating margin by date.
-21.54%11.47%-22.40%18.51%13.60%7.57%10.46%7.45%0.96%-0.40%-1.70%
EPS
YoY % growth
SRPT eps by date.SRPT eps by date.
-6.12
23.79%		2.28
137.25%		-6.65
-391.67%		3.02
145.42%		2.14
-29.13%		1.83
-14.27%		3.50
90.55%		3.32
-5.10%		3.57
7.59%		3.69
3.36%		3.93
6.63%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		1.07
123.23%		0.70
-62.76%		0.42
4,259.36%		0.77
119.50%		0.33
-68.98%		0.65
-7.97%		0.60
45.30%		0.65
-14.84%
Revenue
Q2Q % growth		485.1M
-34.87%		445.13M
-27.16%		394.92M
-1.11%		438.87M
-0.92%		394.05M
-18.77%		405.06M
-9.00%		409.61M
3.72%		417.45M
-4.88%
EBITDA
Q2Q % growth		215.8M
174.31%		59.206M
-56.59%		86.53M
466.48%		93.173M
146.53%		N/AN/AN/AN/A
EBIT
Q2Q % growth		102.19M
134.02%		70.993M
-38.58%		45.157M
171.82%		91.331M
137.31%		41.391M
-59.50%		74.889M
5.49%		74.031M
63.94%		90.329M
-1.10%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SRPT Yearly Revenue VS EstimatesSRPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
SRPT Yearly EPS VS EstimatesSRPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 -4 -6 -8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
31.54%
EPS Next 5 Year
20.10%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-12.48%
Revenue Next 5 Year
-7.26%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
31.21%
EBIT Next 5 Year
17.55%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SAREPTA THERAPEUTICS INC / SRPT Forecast FAQ

What is the average price target for SAREPTA THERAPEUTICS INC (SRPT) stock?

33 analysts have analysed SRPT and the average price target is 30.27 USD. This implies a price increase of 30.32% is expected in the next year compared to the current price of 23.23.

Can you provide the upcoming earnings date for SAREPTA THERAPEUTICS INC?

SAREPTA THERAPEUTICS INC (SRPT) will report earnings on 2026-05-04, after the market close.

Can you provide the consensus estimates for SAREPTA THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of SAREPTA THERAPEUTICS INC (SRPT) is 1.07 USD and the consensus revenue estimate is 485.10M USD.

What is the expected long term growth rate for SRPT stock?

The expected long term growth rate for SAREPTA THERAPEUTICS INC (SRPT) is -12.48%.